Jeffrey D. Abbey

Jeffrey D. Abbey is the current President & CEO at Argos Therapeutics. Prior to this, they were the Chief Executive Officer at NOVADIP Biosciences S.A. from January 2019 to December 2019. Jeffrey has also served as an Independent Consultant from January 2020 to August 2021 and as the President & CEO at Argos Therapeutics from January 2002 to November 2018. Prior to that, they were the Chief Business Officer at Internet Appliance Network from January 1999 to December 2001.

After completing their undergraduate studies at Brown University, Jeffrey D. Abbey went on to earn their MBA from the University of Virginia Darden School of Business. Jeffrey then attended the University of Virginia School of Law, where they earned their JD.

Some individuals on their team include Frederick M. Miesowicz - COO, Doug Plessinger - VP, Clinical & Medical Affairs, and Charles A. Nicolette - Chief Scientific Officer & VP, Research & Development.